Adverum Biotechnologies (ADVM)
(Delayed Data from NSDQ)
$7.05 USD
+0.02 (0.28%)
Updated Sep 12, 2024 04:00 PM ET
After-Market: $7.03 -0.02 (-0.28%) 4:26 PM ET
2-Buy of 5 2
F Value C Growth D Momentum D VGM
Earnings News For ADVM
-
Adverum Biotechnologies: Q2 Earnings Snapshot
-
Adverum Biotechnologies Reports Second Quarter 2024 Financial Results and Provides Program and Corporate Highlights
-
Adverum Biotechnologies: Q1 Earnings Snapshot
-
Adverum Biotechnologies Reports First Quarter 2024 Financial Results and Provides Pipeline Highlights
-
Adverum Biotechnologies (ADVM) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
-
Adverum Biotechnologies: Q4 Earnings Snapshot
-
Adverum Biotechnologies: Q4 Earnings Snapshot
-
Adverum Biotechnologies Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Pipeline Highlights and Corporate Updates
-
Adverum Biotechnologies: Q3 Earnings Snapshot
-
Adverum Biotechnologies Reports Third Quarter 2023 Financial Results and Pipeline Highlights
-
Adverum Biotechnologies: Q2 Earnings Snapshot
-
Adverum Biotechnologies Completes Enrollment of Phase 2 LUNA Trial in Wet AMD and Reports Second Quarter 2023 Financial Results
-
Adverum Biotechnologies: Q1 Earnings Snapshot
-
Adverum Biotechnologies Reports First Quarter 2023 Financial Results
-
Adverum Biotechnologies: Q4 Earnings Snapshot
-
Adverum Biotechnologies: Q4 Earnings Snapshot
-
Adverum Biotechnologies Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Phase 2 LUNA Trial Update
-
Adverum Biotechnologies: Q3 Earnings Snapshot
-
Adverum Biotechnologies Reports Third Quarter 2022 Financial Results
-
Adverum Biotechnologies: Q2 Earnings Snapshot
-
Adverum Biotechnologies Reports Second Quarter 2022 Financial Results
-
Adverum Biotechnologies (ADVM) Reports Q1 Loss, Tops Revenue Estimates
-
Adverum Biotechnologies (ADVM) Reports Q4 Loss, Misses Revenue Estimates
-
Adverum Biotechnologies (ADVM) Reports Q3 Loss, Misses Revenue Estimates
-
Analysts Estimate Adverum Biotechnologies (ADVM) to Report a Decline in Earnings: What to Look Out for